Events

We are thrilled to announce that the Symeres team will be attending the EFMC-ACSMEDI Utrecht 2024 conference. Join Norimasa Morita and Ana Rioz from 8th to 11th April at this prominent event in the field of Medicinal Chemistry and Drug Discovery. In addition, our sr. Vice President of Drug Discovery, and president of the EFMC, Dr. Luc van Hijfte will be present. Luc will chair the session entitled “Recent Advances in Neurodegenerative Diseases” on the afternoon of 11th April. This interesting session includes presentations from H. Rachel Lagiakos from Schrödinger, Maria João Matos of the University of Santiago de Compostela, Peter Buijnsters of Johnson & Johnson, H. George Vandeveer of Biogen, and Imane Ghafir El Idrissi of the Università degli Studi di Bari. We are looking forward to connecting with other industry leaders and experts through the specialized lectures and the company workshops. Be sure to visit our booth to discover how our broad range of chemical services can support your projects. Our team will be on hand to answer any questions you may have, and to explore potential collaborations. Please contact Norimasa Morita via LinkedIn if you would like to book a meeting in advance.

Symeres is happy to announce our participation in the esteemed 40th SCI Process Development Symposium, set to take place from April 10th to 12th, 2024, at Churchill College, Cambridge, UK. At this symposium, our Senior Team Leader, Dr. Michel Leeman, will deliver a captivating presentation entitled “Resolution of Racemates: From Classical to Contemporary.” Dr. Leeman’s talk will shed light on our groundbreaking methodologies in synthetic organic chemistry, particularly focusing on chirality. Additionally, three members of our business development team, namely Andre de Vries, Roger McDonald, and Kirill Kulish, will be in attendance. We extend a warm invitation to join us at this premier event, where industry experts and academic luminaries converge to explore the latest advancements in Process Development. Let’s shape the future of chemistry together!

Join us as the Symeres team embarks on a journey to the vibrant city of Tokyo for CPHI Japan 2024, taking place on April 17th, 18th, and 19th. We eagerly anticipate connecting with you at this premier event. Comprising our team are two notable individuals: Norimasa Morita, our Director of Business Development, and Eric Damen, our Director of Process Research. With fluency in English, Japanese, French, and Dutch, we break down language barriers to foster meaningful conversations. If you’re keen to explore Symeres’ extensive array of integrated drug discovery and development services, we invite you to schedule a meeting during the event. Reach out to Norimasa Morita via his LinkedIn profile to arrange a discussion. Let’s seize this opportunity to collaborate and innovate together!

Symeres is gearing up for the Swiss Biotech Days 2024. Catch us on April 22nd and 23rd at the Congress Center in Basel. Our Senior Vice President Drug Discovery Luc van Hijfte and our Business Development Director Karen Damian will be representing our organization. If you’re curious about Symeres’ extensive range of services and our holistic approach to supporting Pharma and Biotech clients, reach out to Karen Damian via LinkedIn to schedule a meeting. Rest assured, our team is as versatile as a Swiss Army knife, fluent in English, French, Italian, and Dutch!

Join our colleague Sascha Hartmann at the 35th Symposium on Medicinal Chemistry in Eastern England, taking place on April 25th in Stevenage. We are excited to witness the scientific presentations on cutting-edge topics at the forefront of drug discovery. Would you like to engage in scientific discussions and learn more about all the services Symeres has to offer? Stop by our booth; we’re available to assist you!

Symeres is happy to announce our participation in the CPHI North America conference, set to take place from May 7th to 9th, 2024, at Pennsylvania Convention Center, Philadelphia. We eagerly anticipate connecting with you at this premier event. Comprising our team are three notable individuals: Chris Teleha, our VP Business Development, CMC US, Yadan Chen, CEO, and Jay Patel, VP Pharmaceutical Science at Exemplify Biopharma / A Symeres Company. If you’re curious about Symeres’ extensive range of services and especially about drug substance and drug product development, reach out to Chris, Yadan, or Jay via LinkedIn to schedule a meeting. We are looking forward to connecting with industry leaders and experts. Be sure to visit our booth #410 to discover how our broad range of chemical services can support your projects. Our team will be on hand to answer any questions you may have, and to explore potential collaborations.

Symeres will be attending the 19th BIO KOREA conference from May 8 to May 10, 2024, at COEX in Seoul. Representing our organization will be Russell Thomas, our Head of Business Development, and Laszlo Szilagyi, our Business Development Director. If you’re interested in discovering more about Symeres’ extensive service portfolio and integrated solutions for Pharma and Biotech clients, feel free to reach out to Laszlo Szilagyi via his LinkedIn profile to schedule a meeting in advance.